Linaglip-M 2.5/1000 contains Linagliptin Rifampicin
MajorRifampicin induces P-gp and CYP3A4, reducing linagliptin exposure and glucose-lowering effect.
These medicines can affect each other in a serious way. Do not start taking them together unless your doctor has said it is OK. If you already take both, do not stop either one on your own: speak to your doctor or pharmacist soon.
Clinical management: Monitor glycaemic control; consider alternative antidiabetic therapy.